Epion Therapeutics

Burlington, MA · Founded 2012 · Privately Held (backing)

Provider of medical devices designed to develop an innovative treatment for an ectatic corneal disease that can bring early intervention. Epion Therapeutics is based in Burlington, MA and was founded in 2012. Its last reported valuation was $55.5 million in Sep 2022. It has raised $59.2 million.

Last reported valuation
$55.5M
Oct 2026
Priced at
—
Total raised
$59.2M
Last round
—

Who backs Epion Therapeutics?

3 investors
InvestorType
AXA Investment ManagersAsset manager
7G Bioventures—
New World Angels—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Epion Therapeutics investors

3 investors are on record for Epion Therapeutics, including AXA Investment Managers, 7G Bioventures and New World Angels.

Free account
More of Epion Therapeutics with a free account
  • ·Watch Epion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Epion Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View